Gene · 2175
Papers3,803
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,041 to 1,060 of 3,803
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Molecular basis of the association between transcription regulators nuclear respiratory factor 1 and inhibitor of DNA binding protein 3 and the development of microvascular lesions. | Microvasc Res | 2022 | 35143811 | PubTator, text mining | PubMed |
| Disruption of DNA Repair and Survival Pathways through Heat Shock Protein Inhibition by Onalespib to Sensitize Malignant Gliomas to Chemoradiation Therapy. | Clin Cancer Res | 2022 | 35140124 | PubTator, text mining | PubMed |
| Niraparib in patients with metastatic castration-resistant prostate cancer and DNA repair gene defects (GALAHAD): a multicentre, open-label, phase 2 trial. | Lancet Oncol | 2022 | 35131040 | PubTator, text mining | PubMed |
| Germline Cancer Testing in Unselected Patients with Gastric and Esophageal Cancers: A Multi-center Prospective Study. | Dig Dis Sci | 2022 | 35122589 | PubTator, text mining | PubMed |
| Bioinformatics analysis of the clinical relevance of CDCA gene family in prostate cancer. | Medicine (Baltimore) | 2022 | 35119046 | PubTator, text mining | PubMed |
| Screening and identification of novel candidate biomarkers of focal cortical dysplasia type II via bioinformatics analysis. | Childs Nerv Syst | 2022 | 35112146 | PubTator, text mining | PubMed |
| Decade-long leukaemia remissions with persistence of CD4+ CAR T cells. | Nature | 2022 | 35110735 | PubTator, text mining | PubMed |
| Clinical Utility of CDK4/6 Inhibitors in Sarcoma: Successes and Future Challenges. | JCO Precis Oncol | 2022 | 35108033 | PubTator, text mining | PubMed |
| Germline Variants in DNA Damage Repair Genes: An Emerging Role in the Era of Precision Medicine in Pancreatic Adenocarcinoma. | Ann Gastroenterol Surg | 2022 | 35106410 | PubTator, text mining | PubMed |
| ZBTB11 dysfunction: spectrum of brain abnormalities, biochemical signature and cellular consequences. | Brain | 2022 | 35104841 | PubTator, text mining | PubMed |
| Circulating tumor DNA (ctDNA) serial analysis during progression on PD-1 blockade and later CTLA-4 rescue in patients with mismatch repair deficient metastatic colorectal cancer. | J Immunother Cancer | 2022 | 35101943 | PubTator, text mining | PubMed |
| Determinants of Response to Talazoparib in Patients with HER2-Negative, Germline BRCA1/2-Mutated Breast Cancer. | Clin Cancer Res | 2022 | 35091441 | PubTator, text mining | PubMed |
| Multi attribute method implementation using a High Resolution Mass Spectrometry platform: From sample preparation to batch analysis. | PLoS One | 2022 | 35085302 | PubTator, text mining | PubMed |
| Family-based whole-exome sequencing identifies rare variants potentially related to cutaneous melanoma predisposition in Brazilian melanoma-prone families. | PLoS One | 2022 | 35085295 | PubTator, text mining | PubMed |
| DNA Repair Pathways and Their Association With Lethal Prostate Cancer in African American and European American Men. | JNCI Cancer Spectr | 2022 | 35079693 | PubTator, text mining | PubMed |
| Blinatumomab induces complete response in refractory PTLD after hematopoietic cell transplantation. | Blood Adv | 2022 | 35078207 | PubTator, text mining | PubMed |
| Minor PNH clones do not distinguish inherited bone marrow failure syndromes from immune-mediated aplastic anemia. | Blood Adv | 2022 | 35073572 | PubTator, text mining | PubMed |
| Targeting PARP proteins in acute leukemia: DNA damage response inhibition and therapeutic strategies. | J Hematol Oncol | 2022 | 35065680 | PubTator, text mining | PubMed |
| Cell cycle-related genes associate with sensitivity to hydrogen peroxide-induced toxicity. | Redox Biol | 2022 | 35063803 | PubTator, text mining | PubMed |
| Serum albumin as a primary non-covalent binding protein for nitro-oleic acid. | Int J Biol Macromol | 2022 | 35063491 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2175/papers?page=53